XONA GER Week ended 07 Aug 2026

Weekly Investor Report

Exxon Mobil Corporation · Energy · Oil & Gas Integrated

Open interactive chart View report data
Latest close 132.1 EUR
-2.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 3.7% above the Trend Line and sits at 69.1% of its 52-week range. The latest completed week returned -2.1%, after a 8.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 65/100. Near-term considerations: volume confirmation is below normal.

Setup score 52 out of 100
Latest Close 132.1 EUR 7 Aug 2026
1W Return -2.1% latest completed week
4W Return 8.6% short-term follow-through
12W Return -1.6% quarterly tape
Trend Breadth 78.8% 41 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.1% Latest completed week; four-week move 8.6%. Indicator stack 54/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 65/100 38 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.7% above the Trend Line and sits at 69.1% of its 52-week range. The latest completed week returned -2.1%, after a 8.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4112-week average 0.50

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 8.6% over four weeks, -1.6% over 12 weeks, and 49.3% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W-2.1%
4W8.6%
12W-1.6%
26W6.6%
52W49.3%
Active trend streak3 weeks
Active weeks in one year41
Trend breadth78.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.16Latest activity-pressure read.
Pressure change86.1%Four-week change in activity pressure.
Leadership6.70Latest relative-leadership reading.
RS change17.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength36/100Blend of value, momentum, and quality. Underlying universe rank 65; rank 1 is best.
Value37/100Relative valuation strength. Underlying universe rank 64; rank 1 is best.
Quality23/100Profitability and accounting quality. Underlying universe rank 78; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth10/100Revenue and earnings growth. Underlying universe rank 91; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework25/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
21.6x
Price divided by trailing earnings.
Price / sales
1.7x
Market value relative to trailing revenue.
EV / EBITDA
9.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
20.4%
Gross profit retained from each unit of revenue.
Operating margin
9.0%
Operating profit retained from revenue.
Free-cash-flow margin
5.8%
Free cash flow generated from revenue.
Return on invested capital
7.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.5%
Latest one-year revenue growth.
EPS growth
-10.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-23.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.7%
Cash dividends relative to market value.
Buyback yield
3.7%
Net share repurchases relative to market value.
Shareholder yield
6.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment65/100

Weighted news tone is positive across 38 relevant articles.

22 positive · 13 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.2%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+10.0%Week of 15 May.
Worst week-7.2%Week of 8 May.
Latest week-2.1%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses6
Sharp losses6
Recent vol4.8%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape51/100

Trend, activity pressure, participation, and risk combine to a 51/100 tape read.

 Indicator analysis54/100

Latest 12-week confirmation: trend 9/12, activity pressure 0/12, relative leadership 12/12.

Activity pressure 0.41; No reversal markers Factors42/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 12 SVQF25/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 280.0 of 375 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment65/100

Weighted news tone is positive across 38 relevant articles.

ExxonMobil (XOM) Stock Could Be A Bargain On Cash Flow Despite Rich Earnings Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026132.1 EUR-2.1%127.4 EUR101.6 EUR-0.166.7015.9KOn
31 Jul 2026134.9 EUR-2.1%126.5 EUR101.4 EUR-0.4212.5318.0KOn
24 Jul 2026137.8 EUR6.4%125.3 EUR101.1 EUR-0.7218.0352.2KOn
17 Jul 2026129.5 EUR6.5%124.1 EUR100.7 EUR-1.1112.935.3KOff
10 Jul 2026121.6 EUR1.5%123.0 EUR100.4 EUR-1.175.722.1KOff
3 Jul 2026119.8 EUR0.2%122.3 EUR100.2 EUR-0.981.6721.5KOff
26 Jun 2026119.6 EUR-0.1%121.7 EUR99.94 EUR-0.866.4542.5KOn
19 Jun 2026119.8 EUR-6.5%121.0 EUR99.74 EUR-0.735.7478.6KOn
12 Jun 2026128.1 EUR-2.1%120.3 EUR99.51 EUR-0.5915.0274.4KOn
5 Jun 2026130.8 EUR4.9%119.4 EUR99.24 EUR-0.5717.529.3KOn
29 May 2026124.7 EUR-6.3%118.3 EUR98.98 EUR-0.4811.3073.9KOn
22 May 2026133.0 EUR-0.9%117.3 EUR98.74 EUR-0.4220.4682.9KOn
15 May 2026134.2 EUR10.0%116.1 EUR98.46 EUR-0.4327.2258.7KOn
8 May 2026122.0 EUR-7.2%114.8 EUR98.16 EUR-0.3414.6199.4KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context